TABLE 1.
Trial characteristics | Count | % Of trials |
---|---|---|
Pediatric patients eligible | 44 | 5.5 |
Controlled | 329 | 40.9 |
Multi-arm | 93 | 11.6 |
Analysis By Phase | ||
Phase 1 | 146 | 18.1 |
Phase 1/2 | 90 | 11.2 |
Phase 2 | 353 | 43.9 |
Phase 2/3 | 25 | 3.1 |
Phase 3 | 82 | 10.2 |
Phase 4 | 1 | 0.1 |
Not available/Missing | 31 | 3.9 |
Other | 33 | 4.1 |
Analysis By Sponsor Type | ||
Company | 48 | 6.0 |
Hospital/University/Research Institute | 701 | 87.1 |
Collaborative Group | 48 | 6.0 |
Local/National government | 5 | 0.6 |
Other | 3 | 0.4 |